PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1463759
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1463759
Key Highlights
The pharmaceutical logistics market was valued at USD 92.9 billion in 2023, and it will increase to USD 173.7 billion, advancing at over 9.0% compound annual growth rate, by 2030.
Development in the cold-chain sector is a key factor driving the industry expansion.
The pharma cold-chain sector has grown significantly over the years, and cold-chain logistics accounted for a significant development in the pharmaceutical sector, with a surging need for various drugs.
The industry, during the pandemic of COVID-19, performed admirably, even though most vaccine products required a stringent temperature regime (-80 °C), which had hardly been seen before.
Many pharma cold-chain firms, to deal with the emergency, increased their capacity and raised their service levels, and these adjustments are now helping the pharma logistics companies.
Technological improvement is a major trend being witnessed in this industry. RFID allows pallet-level tracking and identification of pharmaceutical goods, therefore, assisting the supply chain authenticity by sustaining optimum hygiene, preserving product integrity, and decreasing cold chain transport losses.
Major pharmaceutical firms are resorting to industry clouds to boost the move of important workloads to the cloud and address most of these challenges.
The main aspects of the cloud for this market are ERP, supply chain orchestration systems and control towers, quality control solutions for laboratories, and MES systems.
Key Insights
Transportation was the largest contributor to the industry in 2023, with a share of approximately 55%, as transportation is an important part of the logistics chain.
The swift rise in the requirement for medicines after the pandemic has boosted inter-country trade volumes of medicines, which, sequentially, assist the expansion of the transportation sector.
The cold-chain category was the largest contributor to the industry in 2023, and it will also advance at the highest rate, of approximately 9.7%, in the years to come.
The widespread import and export of vaccines have resulted in the expansion of the cold-chain category since the pandemic of COVID-19.
The chemical pharma category accounted for the largest share in 2023, of approximately 45%, mainly because of drug businesses' rising need for APIs.
The growing prevalence of chronic ailments has a major impact on the rising need for chemical pharmaceutical logistics.
The seaways category led the industry in 2023, with a share of approximately 50%. Sea transport can house dedicated refrigerated containers (reefers) easily, allowing greater supply chain organization.
Despite the high risk involved in medication handling, sea carriers seem the finest place to control the complete pharma shipping procedure with refrigeration mechanisms.
Europe is leading the industry, and it will further advance at a 9.6% compound annual growth rate during this decade.
The substantial rise in the trade of pharmaceutical goods across major European nations like the U.K., France, and Germany, is accountable for the leading position of the regional industry.
APAC will advance at the fastest CAGR during this decade, because of the flourishing pharmaceutical and healthcare sectors in India, China, and Japan.
The pharmaceutical logistics industry is very fragmented, with several players operating worldwide. These players are continuously looking for growth strategies like acquiring other businesses to maintain their position in the market.